FDA approves cancer drug by Allos Therapeutics
Submitted by Jason Ramsey on Sat, 09/26/2009 - 14:44
The new cancer drug, Folotyn, by Allos Therapeutics, was approved quickly by the FDA to treat the most chronic and aggressive kinds of white blood cell cancers, thereby increasing its share prices by 6 percent.
Latest News
|
|
|
|
|
|
|
|
|
|
|
|
